Max Robotics — Global Service Robot Directory + US Certification

About

Dr. R.D. Clayton is a leading gynaecological oncologist whose research has fundamentally shaped the surgical management of early-stage cervical cancer. His work centers on evaluating treatment outcomes and refining surgical approaches to improve patient survival. Dr. Clayton’s most impactful contribution is his landmark 2019 study, "Survival of women with early‐stage cervical cancer in the UK treated with minimal access and open surgery," which has garnered 24 citations. This critical analysis directly addressed the controversy ignited by two New England Journal of Medicine papers that reported worse outcomes for women undergoing minimal access radical hysterectomy compared to open surgery. By providing robust UK-specific data, Dr. Clayton’s research helped validate these alarming international findings, prompting a major shift in clinical practice away from routine laparoscopic and robotic approaches. His work has been instrumental in establishing evidence-based guidelines, ensuring that patient safety remains paramount in the treatment of gynaecological cancers.